Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development by Montuenga-Badia, L.M. (Luis M.) et al.
 Am. J. Respir. Cell Mol. Biol. Vol. 19, pp. 554–562, 1998
Internet address: www.atsjournals.org
 
Expression of Heterogeneous Nuclear Ribonucleoprotein A2/B1 Changes 
with Critical Stages of Mammalian Lung Development
 
Luis M. Montuenga, Jun Zhou, Ingalill Avis, Michele Vos, Alfredo Martinez, Frank Cuttitta, 
Anthony M. Treston, Mary Sunday, and James L. Mulshine
 
Cell and Cancer Biology Department, Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, 
Maryland; Department of Histology and Pathology, University of Navarra, Pamplona, Spain; and Department of Pathology, 
Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Recent reports have demostrated a link between expression of members of the family of heterogeneous nu-
clear ribonucleoproteins (hnRNPs) and cancer. Overexpression of hnRNP A2/B1 correlated with the even-
tual development of lung cancer in three different clinical cohorts. We have studied the expression of
hnRNP A2/B1 messenger RNA (mRNA) and protein during mammalian development. The expression of
hnRNP A2/B1 mRNA and protein are parallel but change dynamically during critical periods in mouse
pulmonary development. hnRNP A2/B1 is first detected in the lung in the early pseudoglandular period,
peaks at the beginning of the canalicular period, and remains high during the saccular (alveolar) period. In
mouse and rat, hnRNP A2/B1 expression is first evident in the earliest lung buds. As lung development
progresses, the cuboidal epithelial cells of the distal primitive alveoli show high levels of the ribonucle-
oprotein, which is almost undetectable in the proximal conducting airways. The expression of hnRNP A2/
B1 is restricted in mature lung. Similar dynamic pattern of expression through lung development was also
found in rat and human lung. Upregulated expression of hnRNP A2/B1 at critical periods of lung develop-
ment was comparable to the level of expression found in lung cancers and preneoplastic lesions and is con-
sistent with hnRNP A2/B1 overexpression playing an oncodevelopmental role. 
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Heterogeneous nuclear ribonucleoproteins (hnRNPs) are
a group of RNA-binding proteins involved in various steps
of messenger RNA (mRNA) biogenesis such as splicing
and transport to the cytoplasm (1). More than 20 hnRNP
proteins ranging from 34 to 120 kD have been described,
the most abundant of which are denoted the A, B, and C
subtypes. Recent diverse lines of evidence support a rela-
tionship between hnRNPs and growth regulation as well
as carcinogenesis. For example, mRNA levels of hnRNP
A1 and A2 are higher in several immortalized or trans-
formed cell lines than in differentiated human cells (2).
The hnRNP A2 has been reported to interact with calmod-
ulin in rat liver cells (3) and, in an 
 
in vitro
 
 system, with the
nucleotide sequence of the human telomeric DNA repeat
(4). The hnRNP K binds to an upstream region of the
c-
 
myc
 
 gene and has properties of a transcription factor (5,
6). Very recently, the complementary DNA (cDNA) of a
proliferation potential protein (P2P-R), a member of the
hnRNP A/B family, has been shown to encode a protein
domain that binds the tumor supressor protein Rb1, in-
volved in terminal differentiation (7). Members of the
hnRNP-C family undergo targeted proteolytic degrada-
tion by interleukin-1
 
b
 
–converting enzyme-like proteases
during apoptosis (8).
We reported that tumor-associated monoclonal anti-
body 703D4 can be used as an early detection tool for lung
cancer. An immunocytochemical assay of exfoliated bron-
chial epithelial cells of archival sputum specimens from a
high-risk cohort showed 90% accuracy in identifying indi-
viduals who would progress to invasive tumor within two
years (9). Preliminary analysis of two new trials confirms
the utility of this antibody in detecting early lung cancer
(10). We recently demonstrated the principal antigen for
703D4 to be hnRNP A2/B1 (11). We also showed that
hnRNP A2/B1 mRNA was overexpressed and dysregu-
lated in lung cancer cell lines and a transformed bronchial
epithelial cell line when compared with normal primary
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bronchial epithelial cells under conditions of serum starva-
tion (11). The expression of hnRNP A2/B1 in respiratory
tissue from individuals without known lung disease was
not readily evident (12). In respiratory epithelium evalu-
ated from resected primary lung cancers, high hnRNP A2/
B1 expression was found in cells with a range of morpho-
logic appearances from normal to dysplastic to neoplastic
(13).
A close relationship exists between mechanisms of on-
cogenesis and embryonic development, such that many
parallels exist between normal development and malig-
nant growth (14–18). Because these independent findings
all suggest a relationship between cancer and the hnRNPs,
and our previous results point specifically to an association
between hnRNP A2/B1 and lung cancer, it is likely that
hnRNP A2/B1 may have a significant involvement in lung
development. Oncodevelopmental proteins are character-
ized by being expressed in embryonic development, re-
pressed or downregulated during adult life, and reex-
pressed during tumor progression (15–18). Some isolated
reports do show expression or regulation of hnRNP during
development in invertebrates and lower vertebrates: the
Xenopus hnRNP A1, A2, and A3 genes are expressed
throughout development and in adult tissues (19); and it
has been suggested that cell type-specific expression of a
particular 
 
Drosophila
 
 hnRNP A/B protein, hrp40, is re-
quired for normal development (20).
Because the structure of hnRNP A2/B1 is highly con-
served between humans and rodents, and lung develop-
ment is well studied in rodents, we have evaluated expres-
sion of this molecule as both mRNA and protein during
stages of mouse development. Lung development in the
mouse starts at E9.5 with the outgrowth of paired epithe-
lial buds from the foregut endoderm. In the pseudoglandu-
lar stage (E10–E14), epithelial tubes undergo precisely
regulated branching morphogenesis to produce proximal
conducting airways and distal acinar buds. During the
canalicular stage (E14–E16), these buds grow and dilate.
The elongated buds become sac-like structures during the
saccular stage (E16–P0), a process paralleled by the thin-
ning of the surrounding mesenchyma and the invasion of
capillaries, to form a functional air-exchange alveolar com-
partment. To explore the basic biologic principles that may
be involved in the relationship between hnRNP A2/B1
and carcinogenesis, we investigated the expression of this
molecule during normal lung fetal development.
 
Materials and Methods
 
Rodent Tissues
 
Sections of Sprague–Dawley rat and NIH Swiss mouse
staged embryos (Novagene, Madison, WI) were used. All
specimens were fixed for 24 h in 4% buffered paraformal-
dehyde, embedded in paraffin, and sectioned at 7-
 
m
 
m
thickness. For mRNA extraction, E16 and E18 embryos
were used. Dams were obtained from Science Applica-
tions International Co. (Frederick, MD; protocol 95 /125)
and killed by CO
 
2
 
 inhalation. The uterus was quickly re-
moved and kept at 4
 
8
 
C while each embryo was dissected.
Tissues were kept at 
 
2
 
80
 
8
 
C until extracted.
 
Human Tissues
 
Autopsy tissue from human adult and fetal, normal and
pathologic lung tissue samples without patient identifying
information were obtained under an institution-approved
human tissue procurement protocol from the Department
of Pathology, University of Navarra, Pamplona, Spain. A
total of 32 lung tumor cases were studied, including 12
squamous cell carcinomas, 13 adenocarcinomas, and seven
carcinoids. Fetal tissue was from spontaneous miscarriages
ranging from 20 to 40 wk in fetal age. Normal human lung
was from accident trauma victims thought to be nonsmok-
ers. All the human specimens were fixed in 10% buffered
formalin overnight and embedded in paraffin. 
 
Antibodies
 
The mouse monoclonal antibody (MoAb) 703D4 (IgG
 
2
 
b
 
k
 
),
was developed and characterized in our laboratory by sev-
eral molecular techniques that show its specificity for
hnRNP A2/B1 (9, 11, 12). The antibody against gastrin-re-
leasing peptide was also previously characterized by our
group (MoAb 2A11; IgG
 
1k
 
) (21). The polyclonal antibod-
ies to Clara cell secretory protein (CC-10) and type II pneu-
mocytes (surfactant protein C, SP-C) were a kind gift from
Dr. I. Linnoila (National Cancer Institute, Bethesda, MD).
 
Immunohistochemical Analysis
 
We used the Histomouse SP kit (Zymed Laboratories Inc.,
San Francisco, CA) for the immunostaining technique, fol-
lowing manufacturer’s protocol with a minor modification.
Tissues were incubated with primary antibodies diluted to
10 
 
m
 
g/ml at 4
 
8
 
C overnight and then processed as per kit in-
structions. All the experiments included a negative control
slide in which an isotypic mouse monoclonal control anti-
body was used. These negative controls did not show any
nonspecific tissue reactivity. Omission of second layer and
immunostaining with other nonrelated antibodies was also
used as a control for the technique. Immunohistochemical
expression was scored as previously reported (13).
 
In Situ
 
 Hybridization
 
An 1145-base pair hnRNP A2 cDNA obtained by reverse
transcription–polymerase chain reaction from non-small
cell lung cancer (NSCLC) cell line H720 was used to gen-
erate the riboprobe. Labeled probes were prepared by us-
ing a digoxigenin-RNA labeling kit (Boehringer Man-
nheim, Indianapolis, IN) and T7 or Sp6 RNA polymerase.
Pretreatment of the sections included a Proteinase K di-
gestion step (15 
 
m
 
g/ml for 15 min with adult tissues and
2 
 
m
 
g/ml for 12 min for fetal tissues). Hybridization was
performed at 46
 
8
 
C for 20 h in a 20-
 
m
 
l volume containing
the probe at 10 ng/
 
m
 
l. After stringency washes, visuali-
zation of digoxigenin was performed using a digoxigenin
detection kit (Boehringer Mannheim). Sense probe and ri-
bonuclease pretreatment of the sections were used as neg-
ative controls.
 
Isolation of RNA and Northern Blot Analysis
 
Total RNA was purified by the phenol/chloroform method.
A total of 10 
 
m
 
g of total cellular RNA from each tissue was
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used for Northern blot analysis. RNA was transferred pas-
sively to a Nytran (Schleicher & Schuell, Keene, NH)
membrane, hybridized at 68
 
8
 
C for 2 h, and washed. Auto-
radiography was performed according to standard tech-
niques. Probes used for Northern blot analysis were pre-
pared from a plasmid containing full-length cDNA for
hnRNP A2. The hnRNP A1 and K probes were generous
gifts of Drs. G. Dreyfuss (University of Pennsylvania Med-
ical School) and D. Levens (Laboratory of Pathology, Na-
tional Cancer Institute), respectively. Approximately 1 
 
3
 
10
 
6
 
 cpm/ml of probe was used for each Northern blot anal-
ysis. Intensity of the bands was estimated using a Personal
Densitometer SI (Molecular Dynamics, Sunnyvale, CA).
 
Results
 
Expression of hnRNP A2/B1 in Developing
Mammalian Lung
 
In mammalian lung development, the forming airways ex-
pressed hnRNP A2/B1. The highest levels of protein and
mRNA expression were found in the epithelial cells of the
branching system of tubules of the developing mouse
(E10–E16), rat (E12–E18), and human (20 wk onward)
lung. Immunocytochemistry showed that hnRNP A2/B1
was present predominantly in the cytoplasm, but was
sometimes also present in the nucleus, depending on cell
type. In the epithelial cells, cytoplasmic localization was
predominant; whereas in fibroblastic and mononuclear in-
filtrating cells, localization in the nucleus was sometimes
seen, especially in human tissues.
Table 1 summarizes the immunocytochemical results
obtained in relation to hnRNP A2/B1 expression in mouse
and rat lung development. A similar pattern of expression
was found in human development. In general, hnRNP A2/
B1 can be detected for the first time early in the pseudoglan-
dular period, peaks at the end of the pseudoglandular and
the beginning of the canalicular period, and remains high
during the saccular (alveolar) period. In the adult lung of
all the species studied, the expression of hnRNP A2/B1 is
markedly lower than in fetal lung.
 
Patterns of Expression of hnRNP in
Developing Mouse Lung
 
Immunostaining for hnRNP A2/B1 was demonstrated in
the mouse respiratory primordia from E10–E11 onward.
At E11 all the specimens showed very light staining in the
epithelial cells of the lung buds and in some mesenchymal
cells of the forming lung. At E12, two different types of
airways were distinguished in relation to hnRNP A2/B1
expression. The more proximal tubules that develop into
conducting airways, lined by a simple columnar epithe-
lium, were negative for hnRNP A2/B1; at the same time,
the distal undifferentiated cuboidal epithelium lining aci-
nar tubules moderately expressed hnRNP (data not shown).
Around Day 14, a marked increase in the mRNA (Figure
1A) and protein levels (Figures 1B and 1C) of hnRNP A2/
B1 was observed in the distal acinar tubules, whereas ex-
pression in the proximal columnar epithelium of the future
conducting airways remained negative or very low (Figure
1C). On E16, during the late canalicular phase of lung de-
velopment, localization of hnRNP A2/B1 mRNA (Figure
1D) and protein (Figures 1E and 1F) was similar to that
during the pseudoglandular stage. The low cuboidal epi-
thelial cells characteristic of the sac- or pouch-like struc-
tures, resulting from the expansion and differentiation of
the cuboidal epithelial acinar tubules, also expressed hnRNP
(Figure 1F). Expression of hnRNP mRNA was similar to
the pattern of immunostaining (compare Figures 1A and
1B, 1D and 1E). On E14 and E16, levels of hnRNP A2/B1
in the mesenchymal cells of the developing lung were ei-
ther negative or very low. The appropriate controls were
all negative, including 
 
in situ
 
 hybridization using a sense
probe (Figure 1G) and immunostaining using an isotypic
control antibody (Figure 1H). In alveoli of adult mouse
lung, there was no hnRNP A2/B1 protein detectable using
the same concentration of the primary antibody as used
 
TABLE 1
 
Immunocytochemical detection of hnRNP A2/B1 in lung development
 
Subject, Developmental Stage Bronchial Bud Proximal Epithelium Distal Epithelium
 
Mouse
E10 4
 
2 2
 
E12
 
2
 
0 4
E14
 
2
 
0 6
E15
 
2
 
2 6
Mature
 
2
 
0 0
Rat
E14
 
2
 
0 4
E16
 
2
 
2 6
E18
 
2
 
2 4
Mature
 
2
 
0 0
Human
Fetal (20–28 wk)
 
2
 
3 5
Perinatal
 
2
 
2 2
Adult*
 
2
 
0/2 0/2
 
2
 
 indicates structure not present at this stage. Values in the table are the sum of a score for intensity (from 0 
 
5
 
 negative to 3 
 
5
 
 very intense) and a score for exten-
sion (from 0 
 
5
 
 0% to 3 
 
5
 
 100% of the cells).
* Normal bronchial epithelium without observable immunoreactivity, except for focal inflammatory areas where score for immunoreactivity was 2.
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with the embryonal tissues (Figure 1I). The bronchiolar
epithelium of the adult mouse was also either negative or
very weakly positive for hnRNP A2/B1.
 
Patterns of hnRNP Expression in Developing Rat Lung
 
The patterns of expression in developing rat lung were
also analyzed (Figures 1J–1L). The localization of hnRNP
A2/B1 and its mRNA paralleled that found for the mouse,
in particular the early establishment of two patterns of ex-
pression (low in proximal versus high in distal airways)
and the marked increase of hnRNP expression in the de-
veloping distal airways at the end of the canalicular period
(E17–E18 in the rat). Slightly higher expression of hnRNP
A2/B1 in the developing central airways and in some of
the mesenchymal cells of rat lung appeared to be the only
difference between the two species.
 
hnRNP Expression in Developing Human Lung
 
Similar to the findings for mouse and rat, hnRNP A2/B1
expression was found in the epithelial cells of the acinar
Figure 1. Expression of hnRNP A2/B1 in the developing lung of mouse (A–I) and rat (J–L) using in situ hybridization (A, D, G) or im-
munohistochemistry with the monoclonal antibody 703D4 (B, C, E, F, I–L). In both species, stronger levels of hnRNP A2/B1 expression
can be detected in the airway distal epithelium than in the forming central bronchi (see especially C, I, and K). ME14 and ME16: Mouse
embryo of 14 and 16 d; RE15 and RE17: rat embryo of 15 and 17 d. Expression of hnRNP A2/B1 in adult mouse (MA; I) or rat (RA; L)
is greatly reduced compared with that of embryonic lung processed in the same conditions. I is a section of adult mouse immunostained
for hnRNP A2/B1 in the same conditions as (B) or (E). (G) is a sense control for in situ hybridization in a consecutive section of (D).
(H) Section of 14-d mouse embryo equivalent to (B) immunostained using monoclonal antibody isotypic to 703D4 as primary antise-
rum. (Scale bar shown in L corresponds to 70 mm in C, F, I, and L; in panels A, B, D, E, G, H, J, and K it corresponds to 130 mm.)
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tubules of 20-wk gestation human fetal lung (Figure 2A),
which corresponds to the mid-canalicular stage of lung de-
velopment. Consistent with our observations in rodent
lung, human 28-wk gestation fetal lung (late canalicular to
early saccular period) demonstrated high levels of hnRNP
A2/B1 (Figure 2B) with the epithelial cells of primitive al-
veoli strongly expressing hnRNP A2/B1. The sole excep-
tion to the mouse and rat pattern is in the developing in-
trapulmonary bronchi and bronchioles of midgestational
human fetal lung which expressed hnRNP A2/B1. In par-
ticular, immunoreactivity could be observed in the pro-
spective bronchial/bronchiolar epithelium of early (20-wk)
human fetal lung, at least in some of the epithelial cells.
These hnRNP A2/B1-positive cells were not Clara cells or
pulmonary neuroendocrine cells as determined by immun-
ostaining of serial tissue sections for the Clara cell secre-
Figure 2. Immunocytochemical detection of hnRNP in different stages of developing human lung. (A) Lung parenchyma at 20 wk; (B)
lung parenchyma at 28 wk; (C) bronchus circa 25 wk; (D) serial section of (C), to which the isotypic control monoclonal antibody was
applied; (E) bronchus at 28 wk. Note that forming chondrocytes also express hnRNP A2/B1. (F) Bronchiolus of a newborn. (G) Lung
parenchyma of a newborn. (Scale bar in A–F is 70 mm; in G is 40 mm.)
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tory protein (CC10) or for bombesin-like neuropeptide (data
not shown). In later stages of development (28 wk), ex-
pression of hnRNP A2/B1 in the human bronchial and bron-
chiolar epithelium increased markedly (Figures 2C–2E).
In the newborn lung, expression was low but still de-
tectable (Figures 2F and 2G) both in bronchial epithelium
and type II pneumocytes. In some bronchial epithelial co-
lumnar cells, supranuclear granular staining was observed.
In general, the expression of the hnRNP A2/B1 gene in
the alveolar compartment of normal human adult lung was
low and usually undetectable using either immunocyto-
chemistry (Figure 3A1) or 
 
in situ
 
 hybridization (Figure
3A3) detection systems. Type II pneumocytes were usu-
ally negative (Figures 3A1 and 3A2). The expression in
adult bronchial epithelium was also low in most cases, but
was higher in the epithelial cells of some airways present
at uninvolved “normal” areas adjacent to tumors. In these
cases the supranuclear granular staining pattern was readily
observed. Smooth muscle cells of the blood vessels and
chondrocytes of the larger airways occasionally stained
with 703D4 (data not shown).
 
Expression of hnRNP in Hyperplastic and
Neoplastic Lung
 
We previously reported hnRNP A2/B1 expression in “field
carcinogenesis” using non-neoplastic tissues surrounding
resected primary lung tumors (13). In the present study we
used 
 
in situ
 
 localization of hnRNP A2/B1 mRNA to con-
Figure 3. (A) Normal human adult lung. A1: immunostained for hnRNP A2/B1; the lung parenchyma expresses very low, almost unde-
tectable, hnRNP A2/B1. A2: The same area immunostained with an antibody against SP-C to show the abundant type II pneumocyte
population. A3: In situ hybridization for hnRNP A2/B1 in normal lung parenchyma, showing low levels of mRNA. (B) Type II cell hy-
perplasia. B1: Immunostained for hnRNP A2/B1 showing high expression in the hyperplastic type II cells (arrows). B2: Serial section
immunostained with an antibody against SP-C. Hyperplastic type II cells (arrows) are strongly stained. B3: In situ hybridization for
hnRNP A2/B1 in a similar region, showing high mRNA expression in the hyperplastic type II pneumocytes (arrows). (C) Lung adeno-
carcinoma. C1: Immunostained for hnRNP A2/B1 showing high expression in the tumor cells (arrowheads point to a group of tumoral
cells). C2: The same area using an isotypic monoclonal antibody as negative control. C3: In situ hybridization for hnRNP A2/B1 in a se-
rial section, showing high mRNA expression in the tumor cells. (Scale bar in all figures represents 70 mm.)
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firm those previous findings, using previously unanalyzed
cancer cases. High expression of hnRNP was demon-
strated in a variety of NSCLC both at the protein and
mRNA levels (Figure 3C1–3C3). Parallel immunocy-
tochemistry and in situ hybridization was carried out in 22
lung cancer specimens. In 20 (92%) of the cases, both pro-
tein and mRNA for hnRNP A2/B1 were detected; 75% of
these double-positive cases showed comparable expres-
sions of protein and mRNA according to the relative crite-
ria of intensity and extension that we used. Type II cell hy-
perplasia also showed strong expression of hnRNP A2/B1
both by immunocytochemical and in situ hybridization tech-
niques (Figures 3B1–3B3). In these hyperplastic cells, the
hnRNP A2/B1 protein seems to be concentrated in granu-
lar-like cytoplasmic structures, but nuclear staining was
also observed in some tumor cells of specimens indepen-
dent of histology. No apparent correlation between pres-
ence of nuclear staining and tumor type was found. The
levels of intensity of immunostaining of the tumoral cells
were comparable to, and in some cases higher than, those
observed in developing lung epithelial cells. 
Northern Blot Analysis of hnRNP Gene Expression
during Rat Development
Densitometric analysis of Northern blots of fetal, neona-
tal, and adult rat lung mRNAs (Figure 4) showed that the
levels of hnRNP A2/B1 transcripts are significantly higher
during late fetal stages than in the adult stage. The inten-
sity of the band for hnRNP A2 mRNA from E16, E18, P1,
and adult rats diminished with maturation. Decreased
hnRNP A2/B1 mRNA expression was consistently ob-
served in three analyses of replicate samples. Between E16
and adult, lung hnRNP A2/B1 mRNA expression was de-
creased an average of 4.9-fold. Similar decreases in the
levels of mRNA could be detected when using probes spe-
cific for hnRNP A1 and hnRNP K.
Discussion
The present study shows for the first time the expression
of hnRNPs during mammalian development. This data is
consistent with our hypothesis of hnRNP regulation play-
ing a role in lung growth and differentiation and its dysreg-
ulation being involved in the process of carcinogenesis.
We evaluated the full course of fetal lung development in
rodents and found hnRNP A2/B1 expression first evident
in the central regions of the developing lung, with a grad-
ual migration of expression to the periphery of the lung
with a timing that parallels the time course for the matura-
tion of the developing rodent lung. The regulated expres-
sion pattern of hnRNP A2/B1 during fetal development,
downregulation in normal adult tissues, and reexpression
in cancer is consistent with it being an oncofetal molecule.
Our previous report demonstrates that hnRNP A2/B1 ex-
pression is increased in dysregulated cell populations (11).
Developing mouse and rat lung show increased expression
of hnRNP A2/B1 in actively proliferating immature cells.
The hnRNP A2/B1 can be detected for the first time in the
respiratory system in the undifferentiated columnar epi-
thelium of the branching tubular system of the lung pri-
mordium. In the pseudoglandular stage, when the primor-
dial lung buds differentiate into the prospective bronchial
system and the prospective respiratory system (22), detec-
tion of hnRNP A2/B1 is restricted to the immature epithe-
lial cubic cells of the more distal (prospective respiratory)
airways. At the same stage, the more differentiated cells of
the central bronchial system do not express detectable lev-
els of hnRNP A2/B1 protein or mRNA. Expression of
hnRNP A2/B1 in the maturing alveolar system is also high
during the later canalicular period of lung development,
remaining low or undetectable in the columnar epithelium
of the prospective bronchioli. This dynamic pattern of ex-
pression is consistent with tight regulation of this molecule
in fetal development. A similar lung distribution has been
shown for the oncofetal carbohydrate antigen Lex, that is a
mediator of cell–cell interactions (17). A gradient of ex-
pression (higher in epithelium of forming central airways
to lower in distal pre-respiratory ducts) has also been re-
ported for Bcl-2 in fetal mouse lung (23). Bcl-2 has been
proposed to act as a survival factor during morphogenesis
by preventing entry of the cell into the apoptotic pathway.
The pattern of expression of hnRNP A2/B1 in the de-
veloping lung was consistent in the mouse, rat, and human
specimens studied. The only exception was in the epithe-
lium of the developing human intrapulmonary bronchi
and bronchioles, which show expression of hnRNP A2/B1
in a subset of epithelial cells during the earlier stages of fe-
tal development studied (20 wk) and increasing expression
of hnRNP in most of the bronchial epithelial cells during
the perinatal period. The higher expression of hnRNP A2/
B1 in human airway epithelial cells in the late fetal and
early postnatal period might be related to ongoing matura-
tion because the airway mucosa of the newborn human, in
contrast to rodent lung, is not yet fully differentiated (24).
In this study, we observed a sharp rise of hnRNP A2/B1
expression in the type II precursor cells of the embryonic
mouse lung around E14. The type II precursor cell has re-
ceived considerable interest because it shows common an-
tigenic and ultrastructural features with lung cancer cells
Figure 4. RNA blot analy-
sis of different hnRNPs
during rat lung develop-
ment. The housekeeping
gene cyclophilin (Cph)
was blotted at the same
time to show differences
in RNA loading.
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(25). In rat and human fetal lung, hnRNP expression is also
high in the equivalent cell type of the epithelium of the dis-
tal airways at the same developmental period (pseudoglan-
dular stage). The cubic epithelial cell of the forming distal
airways of the rodent and human lung is considered to be
the common progenitor cell for type I and type II pneu-
mocytes (22). During the early stages of mouse lung devel-
opment (E13–E15) distal epithelial cells co-express mark-
ers for multiple differentiated lung epithelial cell types,
including Clara cells and neuroendocrine cells (26). Many
types of lung tumors also express a variety of neuroendo-
crine and non-neuroendocrine marker antigens. Interest-
ingly, the hyperplastic type II cells found in areas of adult
human lung adjacent to tumors consistently show very
high levels of hnRNP A2/B1. Type II cell hyperplasia has
been postulated as a preneoplastic lesion for NSCLC. We
have previously shown increased expression of the enzyme
responsible for post-translational activation of autocrine
peptide hormones in type II hyperplastic cells (27); and a
subset of type II cell hyperplasia has been shown to have
increased p53 immunostaining, consistent with p53 muta-
tion (28), and shows K-ras oncogene activation (29). 
Immunolocalization of hnRNP A2/B1 in the cytoplasm
of many cell types is consistent with the reported function
of this ribonucleoprotein in mRNA shuttling between the
nucleus and the cytosol (30). Although most of the hnRNP
proteins have been immunolocalized to the nucleus, cyto-
plasmic expression of several types of hnRNP proteins has
also been reported in several tissues (31). Accumulation of
the ligand, either in the nucleus or the cytoplasm, may ac-
count for the detection using the reported immunocy-
tochemical method. Conversely, conformational changes
may result in increased recognition of hnRNP A2/B1 in
the cytoplasm. In either case, the pattern of granular stain-
ing in several epithelial cells suggesting cytoplasmic hnRNP
accumulation merits further investigation.
Several authors have reported an association of hnRNP
expression with actively proliferating cells (2, 11, 32). Bia-
monti and colleagues (2) have previously shown the ex-
pression of hnRNP A1 in a human teratocarcinoma cell
line (NT2/D1) and proposed an upregulation of this pro-
tein in highly proliferative cell populations. These authors
also showed high levels of hnRNP expression in trans-
formed cells, which is consistent with our data for hnRNP
A2/B1 in lung tumor cells (11, 13). Preliminary analysis
suggests that the elevation of hnRNP A2/B1 mRNA in the
developing lung may be part of a general increased expres-
sion of the members of the hnRNP family. The hnRNP
A2/B1, A1, and K show increased expression during de-
velopment, supporting this hypothesis and pointing to-
ward a general regulation of the mRNA processing ma-
chinery. An increase in the levels of multiple hnRNP
proteins might be a requirement to sustain the higher ac-
tivity of replication, transcription, and translation that oc-
curs during proliferation and/or differentiation. Certainly
regulation of splicing dynamics could differentiate a ma-
ture from a fetal phenotype and, by analogy, a normal
from a malignant phenotype. To understand the role of
hnRNPs in cancer or development, further discrimination
is needed between the role of hnRNP family members in
defined contexts, such as with spliceosomes, and specific
functions of particular hnRNP molecules as transcription
factors (6, 33), cell cycle modulated nuclear protein kinase
substrates (34), Rb-1 binding proteins (7), and non-termi-
nal differentiation markers (7).
We report here for the first time changes in the levels of
hnRNPs during development, in particular an upregula-
tion of hnRNP A2/B1 during the development of the
mammalian respiratory system, that parallels the overex-
pression of this ribonucleoprotein during lung carcinogen-
esis. The pattern of expression for hnRNP A2/B1 for rat,
mouse, and human lung development is consistent at both
the protein and the message level. Moreover, in human
carcinogenesis, the pattern of hnRNP A2/B1 expression
recapitulates fetal lung development with expression espe-
cially in the case of type II cell hyperplasia. Our data are
consistent with the hypothesis that hnRNP A2/B1 is an on-
codevelopmental protein. This correlative report suggests
that further functional studies, such as with transgenic
knockout mice, should be justified to definitely evaluate
the role of hnRNP A2/B1 in fetal lung development.
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